1. The SVMB is represented on every multidisciplinary consensus document, training guideline, and position paper dealing with vascular disease. This includes the soon-to-be-released Guidelines Document on Peripheral Arterial Disease (chaired by former SVMB president Alan Hirsch) and the Clinical Competency Statement on Vascular Medicine (chaired by former SVMB president Mark Creager). Many fellows of the SVMB are on the writing committees of these important and highly anticipated documents. 2. Former SVMB president Dr William Hiatt is the co-chair for the second version of the Trans-Atlantic Inter-Society Consensus document (known as TASC-2), and the SVMB is represented as a key member of the writing committee. This document will be released in the first half of 2005, and will be modified from its original form to have a significant impact on our primary care colleagues. 3. Drs Marie Gerhard-Herman and Emile Mohler have spearheaded a primer on vascular laboratory testing in collaboration with the American Society of Echocardiography, a document that will certainly further establish our role as experts in vascular diagnostic imaging. In addition, if you have not been to the December New York course run by Drs Mohler and Gerhard-Herman entitled 'Vascular Imaging for the Cardiologist', I urge you to consider attending the third annual course on December 9, 2004. The prior meetings have been so successful that in 2 short years, the meeting has outgrown its space, and will be moving to the New York Hilton Hotel. 4. There are several SVMB fellows who sit on committees of the American College of Cardiology, including the Peripheral Vascular Disease Committee, the Annual Scientific Session content planning committee, and the Council of Cardiovascular Organizations (CCO). Dr Brian Annex has just come from a meeting of the ACC Committee on Ethics, and represents the SVMB in this regard. 5. Last year, we were asked to take a seat at the table of the American College of Cardiology's advocacy committee, which is attempting to harness the power of a coordinated physician voice so that the Federal Government understands the importance of cardiovascular disease, and provides appropriate funding for the screening, diagnosis, and management of the number one killer of Americans annually. Although thwarted by a hurricane last year, Dr Josh Beckman and I will be there again this September. 6. Under the auspices of the Vascular Disease Foundation (of which the SVMB has been a board member since its formation), the SVMB is a founding member of the 'PAD Coalition'. Dr Emile Mohler, Secretary of the SVMB, will attend the inaugural meeting of the PAD Coalition for the purpose of organizing a national public awareness campaign for peripheral arterial disease. Were it not for the efforts of the VDF and specifically, Alan Hirsch, this would not have happened. 7. The SVMB has also been a board member organization of the Intersocietal Commission for the Accreditation of Vascular Laboratories since its inception. Dr John Gocke, former board member of the SVMB, is the immediate past president of the ICAVL, and Dr Thom Rooke represents the SVMB to the ICAVL. Dr Rooke is now in his second term as Treasurer of the ICAVL. We have been active participants in the development of the 'Essentials and Standards' for vascular laboratories, setting the benchmarks which physicians and patients may count on for quality vascular diagnostic testing. And this Fall, the SVMB will join a new alliance, the Coalition for Quality Ultrasonography (CQU), whose mission is to lobby the Federal Government to raise the national standards for ultrasonography throughout medicine, not just in vascular disease. 8. The American Registry for Diagnostic Medical Sonographers (ARDMS) is developing a certification examination for physician interpretation of vascular laboratory testing. I am proud to note that one of the four task force members for this examination is Jeffrey Olin, past president of the SVMB. Dr Olin represents the SVMB in this effort. This is a major victory for the Society.
9. The SVMB has published the definitive eight-part review on peripheral arterial disease as a supplement to the American Journal of Medicine, and has now just published the second in a four-part series on venous thromboembolic disease as the first-ever supplement to the journal Circulation. These two monographs represent the state of the art in their respective disciplines, and are just the beginning of a series of publications initiated and sponsored by the SVMB. 10. I cannot even begin to list all of the SVMB members who are leading the charge in bench and clinical research . . . Dr John Cooke in proteomics; Dr Jeffrey Olin in immunomodulation therapy; Dr Brian Annex in angiogenesis; Drs William Hiatt, Emile Mohler, and Mark Creager in pharmacotherapy for PAD; Dr Judith Regensteiner in physiologic issues in claudication; Drs Chris White, Michael Bacharach, Bruce Gray, and others in the expanding role of endovascular devices for the treatment of vascular disease, and on and on.
However, there remain three major issues which continue to challenge the future of vascular medicine as a specialty, and the SVMB as a professional organization. Allow me to highlight these issues.
1. Dwindling membership: as I stand before you today, we have approximately 350 members. If we are to flourish and continue to gain influence among our peers of larger membership organizations, we must increase our numbers. No fancy e-mail blasts, brochures, postcards, or phone campaigns will do this. To effectively increase our membership, we must each call a colleague, stop a trainee in the hallway, recruit our nurses, nurse practitioners, physician assistants and urge them to join. The application process has been streamlined, and can even be performed by accessing our soon-to-be improved website: www.svmb.org. If each of us in this room speaks with five colleagues upon returning home, we would effectively triple our membership by December 2004. I challenge you all to do this. 2. Fellowship training: the future of our specialty depends on expanding our training programs. I have organized a committee whose task it is to evaluate the challenges and obstacles and recommend methods whereby we expand our fellowship programs. Other members of the SVMB are diligently working on other national strategies to increase the number of training opportunities in vascular medicine, and, through their tireless efforts, I am hopeful that major announcements will be forthcoming in the months ahead. 3. Board certification: one method of securing vascular medicine as a durable specialty is to offer a process whereby physicians with interest and expertise in vascular disease may demonstrate their excellence in the field. This process of board certification is familiar to all of you. Many of you already hold certificates in internal medicine and its subspecialties, including cardiology, or in radiology and vascular surgery, among others. However, in order to assure our national position in the hierarchy of patient care, education, and research in vascular disease, we must offer board certification to our membership and to those physicians interested in vascular disease. It has been this process to which I have dedicated my Presidency. Through many discussions with members of our organization, as well as members of other professional societies, and through consultation with legal experts, it has become clear that this is an obstacle which we will overcome in the near term. Last Fall, I brought this concept to the Board of Trustees of the SVMB, who provided limited resources for me to pursue this charge.
With the help of many of you, and our legal counsel, I am proud to announce the incorporation of a free-standing not-for-profit corporation, The American Board of Vascular Medicine. The ABVM, as it will be known, is the official organization charged with developing and administering a certification process in vascular medicine. Subsequently, I appointed co-chairs, Drs Mark Creager and Bruce Gray, to run the ABVM, along with a Board of Directors, many of whom are familiar to you. Those professionals who successfully pass the examination will receive a certificate from the ABVM demonstrating expertise in vascular medicine. The ABVM, under tireless work from its co-chairs, has contracted with ACT, a well-known professional testing organization, to assist in developing and administering the examination.
Because of the expanding role of endovascular therapy in the management of patients with vascular disease, the ABVM has decided to offer two certifying examinations: one in general vascular medicine, and one in endovascular medicine. The latter examination will be the first available certification process in endovascular medicine that is truly multispecialty in design and scope. Thanks to the help of Dr Chris White, trustee of the SVMB, and after several discussions with the President of The Society for Cardiovascular Angiography and Intervention, Dr John Hodgson, the SCA & I has agreed to join this effort, and is now a formal partner in this process. This gives the ABVM an immediate population of test-takers and potential 'cardcarrying vascular medicine experts'.
The Board of the ABVM met in April in Chicago, Illinois, with ACT, and developed what is arguably the finest curriculum in vascular and endovascular medicine ever devised. This curriculum will serve as the backbone for the test content. The ABVM met again yesterday, and completed item writing assignments for all aspects of the examinations. We are on schedule to offer the first examinations in the Summer=Fall of 2005. Now, let me reassure all of you whose blood pressure and heart rate have begun to rise over the thought of another certification examination: these exams are being written so that a physician who practices vascular and endovascular medicine as a specialty will successfully complete the examination. Finally, board certification in vascular medicine will require a review course in vascular medicine. The SVMB will offer the definitive review course, chaired by Dr Thom Rooke, a trustee of the SVMB and member of the Board of the ABVM, and the details of this review course will be forthcoming.
The future of vascular medicine and the SVMB could not be brighter. The SVMB is on the brink of permanently solidifying our national prominence in vascular disease management, education, and research. The SVMB is committed to your success and future as experts in the field. However, we need the commitment of all of you to be the ambassadors of this effort. You must spread the word regarding the ABVM and the opportunity for Board Certification in vascular and endovascular medicine.
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You must ask for five colleagues to join the SVMB. You must be vocal to the Society and your elected officials about the need for expanded opportunities in vascular fellowship training. Finally, at last year's business meeting, I urged you to step forward to the officers and members of the Board of Trustees and inform us of your areas of interest. Please get involved . . . become a member of a committee . . . of the Board . . . and help to keep the SVMB in the national spotlight in vascular medicine. We'll see you next year in Chicago! Michael R Jaff Society for Vascular Medicine and Biology Annual Scientific Sessions, Anaheim California, USA June 2004 Vascular Medicine 2004; 9: 135-137
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